Literature DB >> 6617533

Spectrum of oral disease induced by drugs and other bioactive agents. Diagnosis and management.

K D Hay, P C Reade.   

Abstract

Entities:  

Mesh:

Year:  1983        PMID: 6617533     DOI: 10.2165/00003495-198326030-00007

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  20 in total

1.  A case-control investigation of alcohol, tobacco, and diet in head and neck cancer.

Authors:  J G Feldman; M Hazan
Journal:  Prev Med       Date:  1975-12       Impact factor: 4.018

2.  UNSIGHTLY TOOTH-DESTRUCTION BY ISOPRENALINE SULPHATE.

Authors:  J S BALL
Journal:  Br Med J       Date:  1965-05-01

Review 3.  Advances in pharmacogenetics.

Authors:  E S Vesell
Journal:  Prog Med Genet       Date:  1973

Review 4.  Pharmacogenetics: defective enzymes in relation to reactions to drugs.

Authors:  B N La Du
Journal:  Annu Rev Med       Date:  1972       Impact factor: 13.739

5.  Effects of penicillamine on the kidney and on taste.

Authors:  I A Jaffe
Journal:  Postgrad Med J       Date:  1968-10       Impact factor: 2.401

6.  Letter: Side-effect of thiocarbamides.

Authors:  J Erikssen; E Seegaard; K Naess
Journal:  Lancet       Date:  1975-01-25       Impact factor: 79.321

7.  Mucosal contact dermatitis due to instant coffee.

Authors:  T S Sonnex; R P Dawber; T J Ryan
Journal:  Contact Dermatitis       Date:  1981-11       Impact factor: 6.600

Review 8.  Etiological and preventive implications in alcohol carcinogenesis.

Authors:  G D McCoy; E L Wynder
Journal:  Cancer Res       Date:  1979-07       Impact factor: 12.701

9.  An epilogue to plasma-cell gingivostomatitis (allergic gingivostamtitis).

Authors:  S Silverman; F Lozada
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1977-02

10.  Adverse reactions to drugs: relationship to immunopathic disease.

Authors:  S Whittingham; I R Mackey
Journal:  Med J Aust       Date:  1976-04-03       Impact factor: 7.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.